Language
中文/繁 English
About Us
Extending human healthy lifespan through gene therapy
SOBEI is a cutting-edge gene therapy company focused on delaying aging and treating age-related diseases. Our core belief is that aging is the fundamental risk factor for most chronic diseases, and it is an intervention that can be addressed.
We employ cutting-edge gene therapy technologies to design precise intervention strategies targeting core aging mechanisms such as telomere attrition, mitochondrial dysfunction, epigenetic alterations, and stem cell exhaustion, thereby delaying or reversing cellular degeneration.
SOBEI is committed to transforming scientific breakthroughs into commercialized products and therapies, advancing the extension of global healthspan, and setting new standards for gene therapy in the field of anti-aging.

Learn More

  • aging It is a disease
    It can be treated

  • Telomere elongation can extend lifespan by 5 to 15 years

  • Longevity Escape Solution
    Extend lifespan by 120+

Aging Science
Your age is the biggest risk factor for your illness< br> Cellular aging is the world's largest unmet medical need, accounting for 63% of global deaths. Currently, 15% of Americans are 65 years old or above. By 2050, this number is expected to surge to over 20%< br> From Alzheimer's disease to cancer, chronic kidney disease, Parkinson's disease, diabetes, myopenia (age-related muscle loss), arthritis, etc., cell aging is the root cause of the most serious health problems we face today. SOBEI's mission is to use gene therapy to treat cellular aging.

Learn More
Subscription
Stay tuned to us anytime